| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 9 | -195K | 100% | $41.84 | -$8.17M |
| Net | -9 | -195K | -100% | -$8.17M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Emil D. Kakkis | President & CEO, Director | $119M | -$5.06M | -4.09% | Feb 28, 2025 |
| Thomas Richard Kassberg | Cbo & Evp | $11.4M | -$254K | -2.18% | Mar 1, 2025 |
| Dennis Karl Huang | Officer | $4.92M | Mar 1, 2025 | ||
| John Richard Pinion | Officer | $4.65M | -$608K | -11.6% | Mar 1, 2025 |
| Erik Harris | EVP & Chief Commercial Officer | $3.7M | -$636K | -14.7% | Mar 1, 2025 |
| Howard Horn | Chief Financial Officer | $3.1M | -$322K | -9.43% | Oct 13, 2025 |
| Eric Crombez | EVP and Chief Medical Officer | $2.81M | -$405K | -12.6% | Apr 21, 2025 |
| Karah Parschauer | EVP and Chief Legal Officer | $2.28M | -$745K | -24.6% | Sep 12, 2025 |
| William Aliski | Director | $1.62M | Jun 24, 2021 | ||
| Theodore Alan Huizenga | SVP, Chief Accounting Officer | $1.47M | -$45.2K | -2.99% | Sep 18, 2025 |
| Mardi Dier | CFO & Executive Vice President | $1.4M | Oct 14, 2022 | ||
| Daniel G. Welch | Director | $1.24M | May 15, 2025 | ||
| Michael Narachi | Director | $1.24M | May 15, 2025 | ||
| Deborah Dunsire | Director | $1.17M | May 15, 2025 | ||
| Matthew K. Fust | Director | $985K | May 15, 2025 | ||
| Shehnaaz Suliman | Director | $985K | May 15, 2025 | ||
| Camille L. Bedrosian | EVP and Chief Medical Officer | $981K | Mar 1, 2023 | ||
| Amrit Ray | Director | $887K | May 15, 2025 | ||
| (Corsee) Sanders Corazon | Director | $574K | -$89.9K | -13.6% | Jun 20, 2025 |
| Lars Ekman | Director | $373K | Jun 24, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|